Accessibility helpSkip to navigationSkip to contentSkip to footer
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign In
  • Home
  • World
    Sections
    • World Home
    • Middle East war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    Most Read
    • Nato’s European members discuss 3% target for defence spending
    • James Dyson is right to fight for British strawberries
    • Demand for UK rented properties falls for first time since pandemic
    • Luxury real estate brokers charged with sex trafficking
    • ‘We need time’: Syrians in Europe resist calls to return home
  • UK
    Sections
    • UK Home
    • UK Economy
    • UK Politics
    • UK Companies
    • Personal Finance
    Most Read
    • Nato’s European members discuss 3% target for defence spending
    • James Dyson is right to fight for British strawberries
    • Demand for UK rented properties falls for first time since pandemic
    • Business leaders warn Reeves about the impact of her Budget tax rises
    • Can Farage turn Reform into a serious contender for government?
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Selfridges’ Thai co-owner says it overpaid for luxury store portfolio
    • James Dyson is right to fight for British strawberries
    • Murdoch family feud left hanging over media empire’s future
    • Demand for UK rented properties falls for first time since pandemic
    • Luxury real estate brokers charged with sex trafficking
  • Tech
    Sections
    • Tech Home
    • Artificial intelligence
    • Semiconductors
    • Cyber Security
    • Social Media
    Most Read
    • The AI agents are coming
    • Romania’s cancelled election is a lesson in social media manipulation
    • Meta donates $1mn to Trump’s inauguration fund
    • Google races to bring AI-powered ‘agents’ to consumers
    • Microsoft’s Suleyman hires ex-DeepMind staff for AI health unit
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Crypto
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Wealth Management
    • Moral Money
    • ETF Hub
    • Fund Management
    • Trading
    Most Read
    • Dollar’s surge sparks biggest fall in emerging market currencies in 2 years
    • The astonishing success of Eurozone bailouts
    • New eras, same bubbles: the forgotten lessons of history
    • FCA looks to fill advice gap on pensions
    • UK fintech Stenn collapsed after Russia money laundering case drew scrutiny
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • James Dyson is right to fight for British strawberries
    • The western myth of the ‘guy we can do business with’
    • The AI agents are coming
    • Romania’s cancelled election is a lesson in social media manipulation
    • The astonishing success of Eurozone bailouts
  • Lex
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Europe's Start-Up Hubs
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    • Working It
    Most Read
    • Nasdaq’s board diversity rules struck down by US court
    • Why business should not ape football when it comes to pay
    • Winner Parmy Olson on AI: ‘It’s not uncontrollable’
    • Pay UK bosses like football stars, says Lord Spencer
    • Remote and offshore work could hurt audit quality, US regulator warns
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Mitch McConnell: ‘We’re in a very, very dangerous world right now’
    • Pat Boonnitipat expected to lose money on his debut film. It’s become an Asian cultural supernova
    • It’s party season — let the covert interiors appraisals begin
    • Murder at the Castle — Miss Merkel finds her freedom
    • Thought the petrol Jaguar was dead? Think again
  • HTSI
MenuSearch
  • Home
  • World
  • UK
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Lex
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Walgreens Boots Alliance Inc

  • Wednesday, 11 December, 2024
    Lex
    Going private will not cure Walgreens’ ailments Premium content

    Across the US, pharmacies are fighting for survival, with prescription drug margins being squeezed

    Pedestrians walk past a Walgreens store in San Francisco,
  • Tuesday, 10 December, 2024
    Walgreens in talks over sale to private equity group Sycamore

    Potential deal highlights mounting distress facing the retail pharmacy industry

    Walgreens pharmacy
  • Tuesday, 22 October, 2024
    US retail
    Walmart and Amazon threaten US drugstores in prescription delivery

    Launch of same-day services adds to pressure on struggling pharmacy chains such as CVS and Walgreens

    A person with pill bottles and an Amazon box
  • Sunday, 30 June, 2024
    Boots UK Ltd
    Boots chief to depart after sale process stalls

    Sebastian James leaves in November as Walgreens indicates IPO or disposal for UK retailer is off the table

    Pedestrians walk past the Boots flagship store on Oxford Street, London
  • Thursday, 27 June, 2024
    Retail sector
    Walgreens shares plummet as discounts and thefts cut into profits

    Owner of Boots and Duane Reade sees stretched customers and lower prescription reimbursements hitting margins

  • Friday, 24 November, 2023
    LexBoots UK Ltd
    Boots: one step closer to the block Premium content

    The transfer of pension obligations fixes one of the parent company’s problems

    People walking in front of a Boots store
  • Friday, 1 September, 2023
    Walgreens Boots chief steps down after latest profit forecast downgrade

    Pharmacy chain struggling with weakening demand for Covid vaccines and rising competition

    Rosalind Brewer
  • Tuesday, 27 June, 2023
    Boots and Walgreens to close 450 branches across UK and US

    Pharmacy group slashes earnings forecast as market softens and customers tighten belts

    A Boots store on Oxford street  in London
  • Monday, 7 November, 2022
    LexMergers & Acquisitions
    Walgreens: US healthcare land-grab intensifies with $9bn deal Premium content

    Purchase is hardly a bargain, but the owner of VillageMD does not have much of a choice

    People walk by a CityMD clinic
  • Monday, 7 November, 2022
    Walgreens affiliate in $9bn deal for doctors’ group Summit Health

    Acquisition set to deliver multibillion profit for private equity investor Warburg Pincus

    Walgreens logo on the side of a building
  • Thursday, 13 October, 2022
    Boots UK Ltd
    Boots sales recover as customers return to shops and travel resumes

    Sales rise 15% in the three months to August despite slump in pharmacy services

    A man walks outside a Boots store in London
  • Friday, 1 July, 2022
    Boots UK Ltd
    Boots left in limbo as bids fail to emerge

    UK pharmacy chain has increased market share but detractors say tired stores have dented its reputation

    Boots on Oxford Street:
  • Tuesday, 28 June, 2022
    Boots UK Ltd
    Walgreens halts sale of Boots chain citing tougher financial conditions

    Owner of UK pharmacy and beauty group blames market turmoil for bids below its expectations

    A Boots sign outside a branch store
  • Thursday, 9 June, 2022
    LexBoots UK Ltd
    Boots/Reliance: Ambani could reinvigorate UK chemist chain Premium content

    A successful bid with Apollo could lead to Boots becoming a high street name in India

    A Boots store in London
  • Thursday, 9 June, 2022
    Boots UK Ltd
    Ambani’s Reliance teams up with Apollo to make binding bid for Boots

    Offer values UK group at between £5bn and £6bn and will allow US parent to keep a minority stake

    A Boots shop in York, UK
  • Wednesday, 27 April, 2022
    Boots UK Ltd
    Apollo and Mukesh Ambani’s Reliance plan joint bid for Boots

    Private equity group teams up with India’s largest company in attempt to buy UK pharmacy chain

    A branch of Boots on Oxford Street in London
  • Tuesday, 1 March, 2022
    UK retail industry
    Boots sale thrown off course by fewer buyers and market turmoil

    Bain Capital and CVC Capital failed to make bid ahead of deadline last week

  • Tuesday, 11 January, 2022
    Boots UK Ltd
    Buyout groups Bain and CVC team up for potential Boots bid

    Private equity companies are jointly considering an approach for UK chemist, say insiders

    A Boots storefront
  • Thursday, 6 January, 2022
    Walgreens Boots Alliance lifts forecast on strong sales

    Highest US growth in two decades helps ‘continued rebound’ in revenue and profit

    Pedestrians wearing protective masks walk past a Walgreens store in San Francisco, California, US
  • Friday, 3 December, 2021
    Boots UK Ltd
    Walgreens lines up Goldman Sachs to explore options for UK’s Boots chain

    Investment bank will weigh possible sale or spin-off of pharmacy chain

    People walk by a Boots store in the UK
  • Monday, 10 May, 2021
    Executive Pay
    US investors revolt against executive pay in record numbers

    Many backlashes stem from plan changes to ensure bonuses were paid out during pandemic

  • Friday, 29 January, 2021
    News in-depth
    Roz Brewer, chemist bringing a new formula on diversity to Walgreens

    Incoming chief will be the only African-American woman running an S&P 500 company when she takes over in March

    Rosalind Brewer at Starbucks’ annual meeting at McCaw Hall in Seattle, Washington, in March 2018
  • Wednesday, 27 January, 2021
    Walgreens Boots Alliance recruits new chief from Starbucks

    Roz Brewer will become only black woman to run an S&P 500 company

  • Wednesday, 6 January, 2021
    AmerisourceBergen Corp
    AmerisourceBergen agrees $6.5bn deal for Alliance Healthcare

    US drug wholesaler’s purchase of distributor owned by Walgreens Boots Alliance aids Europe push

  • Tuesday, 17 November, 2020
    Amazon.com
    Amazon launches online pharmacy in challenge to traditional retailers

    Shares in Walgreens and CVS hit as ecommerce giant offers huge discounts on prescription drugs

    A pharmacist assists a customer at a CVS Health Corp store in Los Angeles
Previous page You are on page 1 Next page

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareersSuppliers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookie PolicyManage CookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsProfessional SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on XFT ChannelsFT Schools

Tools

PortfolioFT AppFT Digital EditionFT EditAlerts HubBusiness School RankingsSubscription ManagerNews feedNewslettersCurrency Converter

Community & Events

FT Live EventsFT ForumsBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2024. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Edition:UK
International
Subscribe for full access

Top sections

  • Home
  • World
    • Middle East war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
  • UK
    • UK Economy
    • UK Politics
    • UK Companies
    • Personal Finance
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
    • Artificial intelligence
    • Semiconductors
    • Cyber Security
    • Social Media
  • Markets
    • Alphaville
    • Markets Data
    • Crypto
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Wealth Management
    • Moral Money
    • ETF Hub
    • Fund Management
    • Trading
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Lex
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Europe's Start-Up Hubs
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    • Working It
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports

FT recommends

  • Alphaville
  • FT Edit
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • Visual and data journalism
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Schools
  • FT Live Events
  • FT Forums
  • Board Director Programme
  • myFT
  • Portfolio
  • FT Digital Edition
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In